TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. TAMPA, FL / ACCESSWIRE /

Group, Inc. Announces Name Change to

FL / ACCESSWIRE / May 28, 2021 / TRxADE Group, Inc. (NASDAQ: MEDS), a health services IT company focused on digitalizing the

retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today

announced that the Company will be changing its name to TRxADE HEALTH, Inc., effective Tuesday, June 1, 2021, to reflect its new

mission and strategic direction of the business.

name change does not affect the rights of the Company's stockholders, creditors, customers or suppliers. The Company's

common stock will continue to trade on the NASDAQ Capital Market under the current trading symbol "MEDS". The

Company's current stockholders will not need to exchange their current stock certificates as the stock certificates reflecting

the Company's prior corporate name will continue to be valid. The name change is expected to be effective on The Nasdaq

Capital Market on Tuesday, June 1, 2021.

2020, we formed several companies focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription

journey and patient engagement in the U.S. We believe the name "TRxADE HEALTH, INC." will better describe the changed

focus of the Company, to a health services IT company focused on digitalizing the retail pharmacy experience," said Suren

Ajjarapu, Chief Executive Officer of the Company.

Group (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug

procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace

serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient

centric telehealth services. For more information on TRxADE Group, please visit the Company's IR website at investors.trxadegroup.com.